JPWO2023145844A5 - - Google Patents

Info

Publication number
JPWO2023145844A5
JPWO2023145844A5 JP2023576995A JP2023576995A JPWO2023145844A5 JP WO2023145844 A5 JPWO2023145844 A5 JP WO2023145844A5 JP 2023576995 A JP2023576995 A JP 2023576995A JP 2023576995 A JP2023576995 A JP 2023576995A JP WO2023145844 A5 JPWO2023145844 A5 JP WO2023145844A5
Authority
JP
Japan
Prior art keywords
amino acid
human
seq
cancer
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576995A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023145844A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/002533 external-priority patent/WO2023145844A1/ja
Publication of JPWO2023145844A1 publication Critical patent/JPWO2023145844A1/ja
Publication of JPWO2023145844A5 publication Critical patent/JPWO2023145844A5/ja
Pending legal-status Critical Current

Links

JP2023576995A 2022-01-27 2023-01-26 Pending JPWO2023145844A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022011107 2022-01-27
PCT/JP2023/002533 WO2023145844A1 (ja) 2022-01-27 2023-01-26 抗ヒトcxcl1抗体

Publications (2)

Publication Number Publication Date
JPWO2023145844A1 JPWO2023145844A1 (https=) 2023-08-03
JPWO2023145844A5 true JPWO2023145844A5 (https=) 2026-01-20

Family

ID=87471580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576995A Pending JPWO2023145844A1 (https=) 2022-01-27 2023-01-26

Country Status (10)

Country Link
US (1) US20250154240A1 (https=)
EP (1) EP4471057A4 (https=)
JP (1) JPWO2023145844A1 (https=)
KR (1) KR20240137027A (https=)
CN (1) CN118591554A (https=)
AU (1) AU2023213334A1 (https=)
CA (1) CA3249959A1 (https=)
IL (1) IL314512A (https=)
TW (1) TW202342528A (https=)
WO (1) WO2023145844A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026060413A1 (en) * 2024-09-16 2026-03-19 Calgent Biotechnology Co., Ltd. Single chain antibodies and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
EP2997042B1 (en) * 2013-05-17 2019-08-07 Centre National de la Recherche Scientifique (CNRS) Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications
US20170058029A1 (en) 2014-05-02 2017-03-02 Chiome Bioscience Inc. Human antibody-producing cell
JP6932365B2 (ja) * 2015-05-14 2021-09-08 公立大学法人大阪 スキルス性胃癌の治療剤、及び胃癌の予後の予測方法
US11292832B2 (en) * 2019-01-28 2022-04-05 Charles J. Rosser Compositions and methods for treatment of diseases involving CXCL1 function
JP7471156B2 (ja) 2020-06-29 2024-04-19 ギガフォトン株式会社 極端紫外光集光ミラー及び電子デバイスの製造方法

Similar Documents

Publication Publication Date Title
JP2021531254A5 (https=)
RU2018114904A (ru) Антитело против garp
JP2021514945A5 (https=)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
JP2018070648A5 (https=)
JP2009525764A5 (https=)
RU2010111896A (ru) Антитело к epha2
RU2014143784A (ru) Фармацевтическая композиция для лечения и/или предотвращения рака желчного пузыря
RU2012154339A (ru) НОВОЕ АНТИТЕЛО ПРОТИВ c-Met
RU2014143785A (ru) Фармацевтическая композиция для лечения и/или предотвращения рака печени
JP2013510868A5 (https=)
JP2021513540A5 (https=)
RU2013152164A (ru) Анти-в7-н3-антитело
JP2014158469A5 (https=)
JP2018502051A5 (https=)
JP2019505527A5 (https=)
JP2020527332A5 (https=)
JP2010516708A5 (https=)
JP2020533362A5 (https=)
JP2021523170A5 (https=)
JP2023133432A5 (https=)
JP2018529661A5 (https=)
JP2025148452A5 (https=)
JPWO2023145844A5 (https=)
JPWO2022270524A5 (https=)